• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

整合应激反应的调控通过线粒体凋亡途径使 U87MG 神经胶质瘤细胞对替莫唑胺敏感。

Regulation of Integrated Stress Response Sensitizes U87MG Glioblastoma Cells to Temozolomide Through the Mitochondrial Apoptosis Pathway.

机构信息

Department of Neurosurgery, China-Japan Union Hospital, Jilin University, Changchun, Jilin, China.

Department of Neurosurgery, The First Affiliated Hospital of Jilin University, Changchun, Jilin, China.

出版信息

Anat Rec (Hoboken). 2018 Aug;301(8):1390-1397. doi: 10.1002/ar.23839. Epub 2018 May 13.

DOI:10.1002/ar.23839
PMID:29698579
Abstract

Glioblastomas are the most frequently diagnosed and worst primary malignancy of the central nervous system, with very poor prognosis. The first-line antiglioma drug temozolomide shows decreasing therapeutic efficacy as treatment progresses. As the integrated stress response (ISR) may be a resistance factor and severe stress might transform the protective effect of the ISR into a damage effect, pharmacological regulation of ISR may be an effective way to sensitize glioma to temozolomide. The aim of the present study was to investigate the mechanisms of the ISR in regulating the therapeutic effect of temozolomide in the human glioblastoma multiforme cell line U87MG. Cultured U87MG cells were treated with temozolomide and PCR array was used to screen key factors in the response to treatment. Cells were co-treated with temozolomide and the eIF2α phosphatase inhibitor salubrinal, and cell apoptosis was measured. Combination treatment with temozolomide and salubrinal had a synergistic effect on cell viability. Salubrinal could upregulate the expression of ATF4, a key factor in the ISR, and enhance temozolomide-induced apoptosis. ATF4 transcriptionally regulated expression of the BH3-ONLY protein NOXA, thus inducing mitochondrial apoptosis. These findings suggest that ISR and ATF4 are involved in the death crosstalk between the endoplasmic reticulum and mitochondria and might be a potential target to enhance the therapeutic effect of temozolomide in patients with glioblastoma multiforme. Anat Rec, 2018. © 2018 Wiley Periodicals, Inc.

摘要

胶质母细胞瘤是中枢神经系统中最常见和最严重的原发性恶性肿瘤,预后极差。一线抗胶质瘤药物替莫唑胺随着治疗的进展,其治疗效果逐渐降低。由于整合应激反应(ISR)可能是一种耐药因素,严重应激可能会将 ISR 的保护作用转化为损伤作用,因此,ISR 的药理学调节可能是一种使胶质母细胞瘤对替莫唑胺敏感的有效方法。本研究旨在探讨 ISR 在调节替莫唑胺对人多形性胶质母细胞瘤 U87MG 细胞系治疗效果中的作用机制。用替莫唑胺处理培养的 U87MG 细胞,并使用 PCR 阵列筛选对治疗反应的关键因素。将细胞与替莫唑胺和 eIF2α 磷酸酶抑制剂 salubrinal 共同处理,并测量细胞凋亡。替莫唑胺和 salubrinal 的联合治疗对细胞活力具有协同作用。Salubrinal 可上调 ISR 中的关键因子 ATF4 的表达,并增强替莫唑胺诱导的细胞凋亡。ATF4 转录调控 BH3-ONLY 蛋白 NOXA 的表达,从而诱导线粒体凋亡。这些发现表明 ISR 和 ATF4 参与内质网和线粒体之间的死亡串扰,可能是增强替莫唑胺治疗多形性胶质母细胞瘤患者疗效的潜在靶点。解剖学记录,2018 年。© 2018 年 Wiley Periodicals, Inc.

相似文献

1
Regulation of Integrated Stress Response Sensitizes U87MG Glioblastoma Cells to Temozolomide Through the Mitochondrial Apoptosis Pathway.整合应激反应的调控通过线粒体凋亡途径使 U87MG 神经胶质瘤细胞对替莫唑胺敏感。
Anat Rec (Hoboken). 2018 Aug;301(8):1390-1397. doi: 10.1002/ar.23839. Epub 2018 May 13.
2
Activating transcription factor 4 mediates adaptation of human glioblastoma cells to hypoxia and temozolomide.激活转录因子 4 介导人胶质母细胞瘤细胞对缺氧和替莫唑胺的适应。
Sci Rep. 2021 Jul 8;11(1):14161. doi: 10.1038/s41598-021-93663-1.
3
miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.miR-126-3p 通过靶向 SOX2 使胶质母细胞瘤细胞对替莫唑胺敏感,从而使 Wnt/β-catenin 信号失活。
Life Sci. 2019 Jun 1;226:98-106. doi: 10.1016/j.lfs.2019.04.023. Epub 2019 Apr 10.
4
Endoplasmic reticulum stress-inducing drugs sensitize glioma cells to temozolomide through downregulation of MGMT, MPG, and Rad51.内质网应激诱导药物通过下调MGMT、MPG和Rad51使胶质瘤细胞对替莫唑胺敏感。
Neuro Oncol. 2016 Aug;18(8):1109-19. doi: 10.1093/neuonc/now022. Epub 2016 Mar 6.
5
Apoptosis induction in human glioblastoma multiforme T98G cells upon temozolomide and quercetin treatment.替莫唑胺和槲皮素处理后人多形性胶质母细胞瘤T98G细胞中的凋亡诱导
Tumour Biol. 2013 Aug;34(4):2367-78. doi: 10.1007/s13277-013-0785-0. Epub 2013 Apr 12.
6
The SIAH1-HIPK2-p53ser46 Damage Response Pathway is Involved in Temozolomide-Induced Glioblastoma Cell Death.SIAH1-HIPK2-p53ser46 损伤反应通路参与替莫唑胺诱导的胶质母细胞瘤细胞死亡。
Mol Cancer Res. 2019 May;17(5):1129-1141. doi: 10.1158/1541-7786.MCR-18-1306. Epub 2019 Feb 22.
7
Effects of temozolomide on U87MG glioblastoma cell expression of CXCR4, MMP2, MMP9, VEGF, anti-proliferatory cytotoxic and apoptotic properties.替莫唑胺对 U87MG 脑胶质瘤细胞 CXCR4、MMP2、MMP9、VEGF 表达、抗增殖细胞毒性和促凋亡作用的影响。
Mol Biol Rep. 2020 Feb;47(2):1187-1197. doi: 10.1007/s11033-019-05219-2. Epub 2020 Jan 2.
8
Inhibition of human peptide deformylase by actinonin sensitizes glioblastoma cells to temozolomide chemotherapy.抑肽酶通过放线菌酮抑制人肽脱甲酰酶可使胶质母细胞瘤细胞对替莫唑胺化疗敏感。
Exp Cell Res. 2022 Nov 15;420(2):113358. doi: 10.1016/j.yexcr.2022.113358. Epub 2022 Sep 15.
9
Are There Thresholds in Glioblastoma Cell Death Responses Triggered by Temozolomide?替莫唑胺诱导胶质母细胞瘤细胞死亡反应是否存在阈值?
Int J Mol Sci. 2019 Mar 28;20(7):1562. doi: 10.3390/ijms20071562.
10
Inhibition of Cyclin D1 Expression in Human Glioblastoma Cells is Associated with Increased Temozolomide Chemosensitivity.人胶质母细胞瘤细胞中细胞周期蛋白D1表达的抑制与替莫唑胺化疗敏感性增加相关。
Cell Physiol Biochem. 2018;51(6):2496-2508. doi: 10.1159/000495920. Epub 2018 Dec 11.

引用本文的文献

1
Activation of Unfolded Protein Response Pathway in Malignancies: Interplay with Extracellular Matrix and Targeting Perspectives.恶性肿瘤中未折叠蛋白反应途径的激活:与细胞外基质的相互作用及靶向治疗前景
Cancers (Basel). 2025 Jun 13;17(12):1972. doi: 10.3390/cancers17121972.
2
DEML: Drug Synergy and Interaction Prediction Using Ensemble-Based Multi-Task Learning.DEML:基于集成的多任务学习的药物协同和相互作用预测。
Molecules. 2023 Jan 14;28(2):844. doi: 10.3390/molecules28020844.
3
The Identification of Necroptosis-Related Subtypes, the Construction of a Prognostic Model, and the Characterization of the Tumor Microenvironment in Gliomas.
胶质瘤中坏死性凋亡相关亚型的鉴定、预后模型的构建及肿瘤微环境的特征分析
Front Oncol. 2022 Jun 2;12:899443. doi: 10.3389/fonc.2022.899443. eCollection 2022.
4
Aberrant Expression of ADARB1 Facilitates Temozolomide Chemoresistance and Immune Infiltration in Glioblastoma.ADARB1的异常表达促进胶质母细胞瘤对替莫唑胺的化疗耐药及免疫浸润。
Front Pharmacol. 2022 Feb 1;13:768743. doi: 10.3389/fphar.2022.768743. eCollection 2022.
5
Over-expression of lncRNA TMEM161B-AS1 promotes the malignant biological behavior of glioma cells and the resistance to temozolomide via up-regulating the expression of multiple ferroptosis-related genes by sponging hsa-miR-27a-3p.lncRNA TMEM161B-AS1的过表达通过海绵化hsa-miR-27a-3p上调多个铁死亡相关基因的表达,从而促进胶质瘤细胞的恶性生物学行为和对替莫唑胺的耐药性。
Cell Death Discov. 2021 Oct 23;7(1):311. doi: 10.1038/s41420-021-00709-4.
6
Activating transcription factor 4 mediates adaptation of human glioblastoma cells to hypoxia and temozolomide.激活转录因子 4 介导人胶质母细胞瘤细胞对缺氧和替莫唑胺的适应。
Sci Rep. 2021 Jul 8;11(1):14161. doi: 10.1038/s41598-021-93663-1.
7
Autophagy activated by silibinin contributes to glioma cell death via induction of oxidative stress-mediated BNIP3-dependent nuclear translocation of AIF.水飞蓟宾激活的自噬通过诱导氧化应激介导的AIF依赖BNIP3的核转位导致胶质瘤细胞死亡。
Cell Death Dis. 2020 Aug 14;11(8):630. doi: 10.1038/s41419-020-02866-3.
8
Inhibition of pyruvate dehydrogenase kinase‑1 by dicoumarol enhances the sensitivity of hepatocellular carcinoma cells to oxaliplatin via metabolic reprogramming.二苯乙烯抑制丙酮酸脱氢酶激酶-1 通过代谢重编程增强肝癌细胞对奥沙利铂的敏感性。
Int J Oncol. 2020 Sep;57(3):733-742. doi: 10.3892/ijo.2020.5098. Epub 2020 Jul 10.
9
Salubrinal in Combination With 4E1RCat Synergistically Impairs Melanoma Development by Disrupting the Protein Synthetic Machinery.Salubrinal与4E1RCat联合使用通过破坏蛋白质合成机制协同损害黑色素瘤发展。
Front Oncol. 2020 Jun 19;10:834. doi: 10.3389/fonc.2020.00834. eCollection 2020.
10
Bim, Puma and Noxa upregulation by Naftopidil sensitizes ovarian cancer to the BH3-mimetic ABT-737 and the MEK inhibitor Trametinib.萘哌地尔上调 Bim、Puma 和 Noxa,使卵巢癌细胞对 BH3 模拟物 ABT-737 和 MEK 抑制剂曲美替尼敏感。
Cell Death Dis. 2020 May 18;11(5):380. doi: 10.1038/s41419-020-2588-8.